Evidence map›Paper›PMID 23388463›Full record

ArticleCell cycle (Georgetown, Tex.)2013

Cigarette smoke metabolically promotes cancer, via autophagy and premature aging in the host stromal microenvironment.

Ahmed F Salem, Mazhar Salim Al-Zoubi, Diana Whitaker-Menezes, Ubaldo E Martinez-Outschoorn, Rebecca Lamb, James Hulit, Anthony Howell, Ricardo Gandara, Marina Sartini, Ferruccio Galbiati and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Key promoters of tumor hallmarks.International journal of clinical oncology · 2022
    Review
  7. Review
  8. Article
  9. Article
  10. Effects of Inhaled Tobacco Smoke on the Pulmonary Tumor Microenvironment.Advances in experimental medicine and biology · 2020
    Review
  11. Article
  12. Article
  13. Blood Cadmium Level Is Associated with Short Progression-Free Survival in Nasopharyngeal Carcinoma.International journal of environmental research and public health · 2019
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Nicotine Reduces Survival via Augmentation of Paracrine HGF-MET Signaling in the Pancreatic Cancer Microenvironment.Clinical cancer research : an official journal of the American Association for Cancer Research · 2016
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 6 countries.

Ahmed F SalemKimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA. salem_ahmed82@yahoo.com
Mazhar Salim Al-Zoubi
Diana Whitaker-Menezes
Ubaldo E Martinez-Outschoorn
Rebecca Lamb
James Hulit
Anthony Howell
Ricardo Gandara
Marina Sartini
Ferruccio Galbiati
Generoso Bevilacqua
Federica Sotgia
Michael P Lisanti
Institute of Cancer Research · CAPhiladelphia University · USSidney Kimmel Cancer Center · USUniversity of Manchester · GBBreakthrough · USDepartment of Medical Sciences · BYUniversity of Pisa · ITUniversity of Pittsburgh · US

Funding

Caveolin 1: a novel modulator of the PP2A/ATM/p53 pathwayR01AG030636 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GALBIATI, FERRUCCIO · 2009 to 2013
$1.5M
NIA NIH HHS R01 AG030636
6 · The paper itself

Abstract

Cigarette smoke has been directly implicated in the disease pathogenesis of a plethora of different human cancer subtypes, including breast cancers. The prevailing view is that cigarette smoke acts as a mutagen and DNA damaging agent in normal epithelial cells, driving tumor initiation. However, its potential negative metabolic effects on the normal stromal microenvironment have been largely ignored. Here, we propose a new mechanism by which carcinogen-rich cigarette smoke may promote cancer growth, by metabolically "fertilizing" the host microenvironment. More specifically, we show that cigarette smoke exposure is indeed sufficient to drive the onset of the cancer-associated fibroblast phenotype via the induction of DNA damage, autophagy and mitophagy in the tumor stroma. In turn, cigarette smoke exposure induces premature aging and mitochondrial dysfunction in stromal fibroblasts, leading to the secretion of high-energy mitochondrial fuels, such as L-lactate and ketone bodies. Hence, cigarette smoke induces catabolism in the local microenvironment, directly fueling oxidative mitochondrial metabolism (OXPHOS) in neighboring epithelial cancer cells, actively promoting anabolic tumor growth. Remarkably, these autophagic-senescent fibroblasts increased breast cancer tumor growth in vivo by up to 4-fold. Importantly, we show that cigarette smoke-induced metabolic reprogramming of the fibroblastic stroma occurs independently of tumor neo-angiogenesis. We discuss the possible implications of our current findings for the prevention of aging-associated human diseases and, especially, common epithelial cancers, as we show that cigarette smoke can systemically accelerate aging in the host microenvironment. Finally, our current findings are consistent with the idea that cigarette smoke induces the "reverse Warburg effect," thereby fueling "two-compartment tumor metabolism" and oxidative mitochondrial metabolism in epithelial cancer cells.

Indexed as

AutophagyCellular SenescenceTumor MicroenvironmentCell ProliferationCyclin-Dependent Kinase Inhibitor p21DNA DamageDown-RegulationFibroblastsGlycolysisHumansKetone BodiesLactic AcidMitochondriaMitophagyModels, BiologicalNeoplasmsCyclin-Dependent Kinase Inhibitor p21Ketone BodiesLactic AcidRetinoblastoma ProteinTumor Suppressor Protein p53autophagybreast cancercancer preventioncarcinogenscigarette smokeketone bodieslactatemicroenvironmentmitochondrial dysfunctionpremature agingsenescencetumor growth

Identifiers

PMID23388463
PMCPMC3610729
OpenAlexW2030653144

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.